Essity Results Presentation Deck

Health & Medical Q2 2023 vs Q2 2022 ■ ▪ Lower volumes in Incontinence Products related to exits of contracts with inadequate profitability ■ Strong organic sales growth with higher prices e9 ee9 es Significant improvement in adjusted EBITA and adjusted EBITA margin Higher prices and better mix Cost savings Significant cost inflation - - 1) Including organic sales growth and acquisitions 2) Excluding items affecting comparability essity Half-year Report 2023 Net Sales SEK 7,051m +15% -3.5% Volume +11.5% Price/ Mix % Net Sales: Sales Growth¹) +8.0% Organic: +8.0% +7.1% Adjusted EBITA²) Organic Sales Growth SEK 943m +40% 79% +11.4% Mature Emerging Markets Markets 21% Adjusted EBITA Margin²) 13.4% +240bps +10.1% 59% +5.1% Incontinence Medical Solutions Products Health Care 41% July 20,2023 12

View entire presentation